Yeast mutants conferring resistance to toxic effects of cloned human insulin-like growth factor I
- 1 November 1989
- Vol. 83 (1) , 47-55
- https://doi.org/10.1016/0378-1119(89)90402-2
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Expression, purification and characterization of recombinant human insulin-like growth factor I in yeastGene, 1988
- Cloning of human lysozyme gene and expression in the yeast Saccharomyces cerevisiaeGene, 1988
- Characterization of recombinant human epidermal growth factor produced in yeastBiochemistry, 1988
- High level expression of proinsulin in the yeast, Saccharomyces cerevisiaeGene, 1987
- Improved Secretion of Heterologous Proteins bySaccharomyces cerevisiae: Effects of Promoter Substitution in Alpha-Factor FusionsDNA, 1986
- PEP4 gene of Saccharomyces cerevisiae encodes proteinase A, a vacuolar enzyme required for processing of vacuolar precursors.Molecular and Cellular Biology, 1986
- Saccharomyces cerevisiae secretes and correctly processes human interferon hybrid proteins containing yeast invertase signal peptides.Molecular and Cellular Biology, 1986
- Actions of Insulin-Like Growth FactorsAnnual Review of Physiology, 1985
- A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistanceMolecular Genetics and Genomics, 1984
- Sterile host yeasts (SHY): A eukaryotic system of biological containment for recombinant DNA experimentsGene, 1979